Radio and PodcastRadio and PodcastLive Radio & Podcasts
FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins artwork
Science & Medicine

FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins

FDA Drug Safety Podcasts by U.S. Food and Drug Administration, Center for Drug Evaluation and Research

Jul 22, 20213:00Science & Medicine

Listen to an audio podcast of the July 20, 2021 FDA Drug Safety Communication, FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients s...

About This Episode

FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins is an episode from FDA Drug Safety Podcasts by U.S. Food and Drug Adminis...

Podcast

This episode belongs to FDA Drug Safety Podcasts.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jul 22, 2021, 3:00 long, audio available.

Related Episodes

Continue listening to more episodes from FDA Drug Safety Podcasts.